CommentaryCOLLABORATIVE ENVIRONMENTS

Consortium Sandbox: Building and Sharing Resources

See allHide authors and affiliations

Science Translational Medicine  25 Jun 2014:
Vol. 6, Issue 242, pp. 242cm6
DOI: 10.1126/scitranslmed.3009024
  • Fig. 1 Number of consortia launched.

    By year, 1995 to 2013. (A) All consortia. (B) By continent.

    CREDIT: H. McDONALD/SCIENCE TRANSLATIONAL MEDICINE
  • Fig. 2

    Consortia: Who and why? A total of 369 consortia were studied. (A) Sectors that initiated a consortium. (B) Growth of consortia by top three initiating sectors (government, third-party, and industry). (C) Sectors intended to benefit by consortium activities (n = 369), by initiating sector. (D) Growth of consortia focused on advancing device research. The color key applies to (A), (B), and (C). For consortia launched in Europe and North America, n = 208 and 144, respectively.

    CREDIT: H. McDONALD/SCIENCE TRANSLATIONAL MEDICINE
  • Fig. 3 Initiators and outputs.

    (A) Intended products of consortia, by initiating sector. (B) Sectors that initiate consortia, by intended product.

    CREDIT: H. McDONALD/SCIENCE TRANSLATIONAL MEDICINE
  • Table 1. Disease-focused consortia.

    Products and locations for the top four diseases. Categorization of rare diseases was based on information in publicly available databases (24, 25). One caveat with this broad categorization is that therapeutic areas such as oncology, Alzheimer’s disease, and diabetes represent an aggregate of multiple subtypes, many of which may be rare diseases in themselves.

    [CREDIT (background): Science collaborations map/computed by O. H. Beauchesne, using date from Scopus and Science-Metrix]
  • Fig. 4 Focus by disease.

    For the top four diseases (AD, oncology, diabetes, and rare diseases). (A) Disease-focused consortia by initiating sector. (B) Sector interests in initiating disease-focused consortia.

    CREDIT: H. McDONALD/SCIENCE TRANSLATIONAL MEDICINE

Supplementary Materials

  • Supplementary Material for:

    Consortium Sandbox: Building and Sharing Resources

    Mark D. Lim

    *Corresponding author. E-mail: mlim{at}fastercures.org

    Published 25 June 2014, Sci. Transl. Med. 6, 242cm6 (2014)
    DOI: 10.1126/scitranslmed.3009024

    This PDF file includes:

    • Supplementary methods.
    • Table S1. Consortium Web sites.
    • Table S2. Sectors or groups that initiate consortia through development of strategic research agendas.
    • Table S3. Examples of consortium output.

    [Download PDF]